1 Study Coverage 1.1 Dimenhydrinate Product Introduction 1.2 Global Dimenhydrinate Outlook 2017 VS 2022 VS 2028 1.2.1 Global Dimenhydrinate Sales in US$ Million for the Year 2017-2028 1.2.2 Global Dimenhydrinate Sales in Volume for the Year 2017-2028 1.3 United States Dimenhydrinate Outlook 2017 VS 2022 VS 2028 1.3.1 United States Dimenhydrinate Sales in US$ Million for the Year 2017-2028 1.3.2 United States Dimenhydrinate Sales in Volume for the Year 2017-2028 1.4 Dimenhydrinate Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States Dimenhydrinate in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of Dimenhydrinate Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 Dimenhydrinate Market Dynamics 1.5.1 Dimenhydrinate Industry Trends 1.5.2 Dimenhydrinate Market Drivers 1.5.3 Dimenhydrinate Market Challenges 1.5.4 Dimenhydrinate Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 Dimenhydrinate Market Segment by Type 2.1.1 Oral 2.1.2 Injection 2.2 Global Dimenhydrinate Market Size by Type 2.2.1 Global Dimenhydrinate Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global Dimenhydrinate Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global Dimenhydrinate Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States Dimenhydrinate Market Size by Type 2.3.1 United States Dimenhydrinate Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States Dimenhydrinate Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States Dimenhydrinate Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 Dimenhydrinate Market Segment by Application 3.1.1 Hospital 3.1.2 Drug Store 3.1.3 On-line 3.2 Global Dimenhydrinate Market Size by Application 3.2.1 Global Dimenhydrinate Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global Dimenhydrinate Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global Dimenhydrinate Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States Dimenhydrinate Market Size by Application 3.3.1 United States Dimenhydrinate Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States Dimenhydrinate Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States Dimenhydrinate Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global Dimenhydrinate Competitor Landscape by Company 4.1 Global Dimenhydrinate Market Size by Company 4.1.1 Top Global Dimenhydrinate Manufacturers Ranked by Revenue (2021) 4.1.2 Global Dimenhydrinate Revenue by Manufacturer (2017-2022) 4.1.3 Global Dimenhydrinate Sales by Manufacturer (2017-2022) 4.1.4 Global Dimenhydrinate Price by Manufacturer (2017-2022) 4.2 Global Dimenhydrinate Concentration Ratio (CR) 4.2.1 Dimenhydrinate Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Dimenhydrinate in 2021 4.2.3 Global Dimenhydrinate Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Dimenhydrinate Manufacturing Base Distribution, Product Type 4.3.1 Global Dimenhydrinate Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers Dimenhydrinate Product Type 4.3.3 Date of International Manufacturers Enter into Dimenhydrinate Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States Dimenhydrinate Market Size by Company 4.5.1 Top Dimenhydrinate Players in United States, Ranked by Revenue (2021) 4.5.2 United States Dimenhydrinate Revenue by Players (2020, 2021 & 2022) 4.5.3 United States Dimenhydrinate Sales by Players (2020, 2021 & 2022) 5 Global Dimenhydrinate Market Size by Region 5.1 Global Dimenhydrinate Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Dimenhydrinate Market Size in Volume by Region (2017-2028) 5.2.1 Global Dimenhydrinate Sales in Volume by Region: 2017-2022 5.2.2 Global Dimenhydrinate Sales in Volume Forecast by Region (2023-2028) 5.3 Global Dimenhydrinate Market Size in Value by Region (2017-2028) 5.3.1 Global Dimenhydrinate Sales in Value by Region: 2017-2022 5.3.2 Global Dimenhydrinate Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Dimenhydrinate Market Size YoY Growth 2017-2028 6.1.2 North America Dimenhydrinate Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 United States 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Dimenhydrinate Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Dimenhydrinate Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 China Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.3 Europe 6.3.1 Europe Dimenhydrinate Market Size YoY Growth 2017-2028 6.3.2 Europe Dimenhydrinate Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Dimenhydrinate Market Size YoY Growth 2017-2028 6.4.2 Latin America Dimenhydrinate Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Dimenhydrinate Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Dimenhydrinate Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 UAE 7 Company Profiles 7.1 Bristol-Myers Squibb 7.1.1 Bristol-Myers Squibb Corporation Information 7.1.2 Bristol-Myers Squibb Description and Business Overview 7.1.3 Bristol-Myers Squibb Dimenhydrinate Sales, Revenue and Gross Margin (2017-2022) 7.1.4 Bristol-Myers Squibb Dimenhydrinate Products Offered 7.1.5 Bristol-Myers Squibb Recent Development 7.2 Baxter Healthcare 7.2.1 Baxter Healthcare Corporation Information 7.2.2 Baxter Healthcare Description and Business Overview 7.2.3 Baxter Healthcare Dimenhydrinate Sales, Revenue and Gross Margin (2017-2022) 7.2.4 Baxter Healthcare Dimenhydrinate Products Offered 7.2.5 Baxter Healthcare Recent Development 7.3 Watson Laboratories 7.3.1 Watson Laboratories Corporation Information 7.3.2 Watson Laboratories Description and Business Overview 7.3.3 Watson Laboratories Dimenhydrinate Sales, Revenue and Gross Margin (2017-2022) 7.3.4 Watson Laboratories Dimenhydrinate Products Offered 7.3.5 Watson Laboratories Recent Development 7.4 Pfizer 7.4.1 Pfizer Corporation Information 7.4.2 Pfizer Description and Business Overview 7.4.3 Pfizer Dimenhydrinate Sales, Revenue and Gross Margin (2017-2022) 7.4.4 Pfizer Dimenhydrinate Products Offered 7.4.5 Pfizer Recent Development 7.5 Nexgen Pharma 7.5.1 Nexgen Pharma Corporation Information 7.5.2 Nexgen Pharma Description and Business Overview 7.5.3 Nexgen Pharma Dimenhydrinate Sales, Revenue and Gross Margin (2017-2022) 7.5.4 Nexgen Pharma Dimenhydrinate Products Offered 7.5.5 Nexgen Pharma Recent Development 7.6 Goodwill Pharma 7.6.1 Goodwill Pharma Corporation Information 7.6.2 Goodwill Pharma Description and Business Overview 7.6.3 Goodwill Pharma Dimenhydrinate Sales, Revenue and Gross Margin (2017-2022) 7.6.4 Goodwill Pharma Dimenhydrinate Products Offered 7.6.5 Goodwill Pharma Recent Development 7.7 Hennig Arzneimittel 7.7.1 Hennig Arzneimittel Corporation Information 7.7.2 Hennig Arzneimittel Description and Business Overview 7.7.3 Hennig Arzneimittel Dimenhydrinate Sales, Revenue and Gross Margin (2017-2022) 7.7.4 Hennig Arzneimittel Dimenhydrinate Products Offered 7.7.5 Hennig Arzneimittel Recent Development 7.8 Zambon 7.8.1 Zambon Corporation Information 7.8.2 Zambon Description and Business Overview 7.8.3 Zambon Dimenhydrinate Sales, Revenue and Gross Margin (2017-2022) 7.8.4 Zambon Dimenhydrinate Products Offered 7.8.5 Zambon Recent Development 7.9 Apotex 7.9.1 Apotex Corporation Information 7.9.2 Apotex Description and Business Overview 7.9.3 Apotex Dimenhydrinate Sales, Revenue and Gross Margin (2017-2022) 7.9.4 Apotex Dimenhydrinate Products Offered 7.9.5 Apotex Recent Development 7.10 Teva 7.10.1 Teva Corporation Information 7.10.2 Teva Description and Business Overview 7.10.3 Teva Dimenhydrinate Sales, Revenue and Gross Margin (2017-2022) 7.10.4 Teva Dimenhydrinate Products Offered 7.10.5 Teva Recent Development 7.11 Mylan 7.11.1 Mylan Corporation Information 7.11.2 Mylan Description and Business Overview 7.11.3 Mylan Dimenhydrinate Sales, Revenue and Gross Margin (2017-2022) 7.11.4 Mylan Dimenhydrinate Products Offered 7.11.5 Mylan Recent Development 7.12 Cinfa 7.12.1 Cinfa Corporation Information 7.12.2 Cinfa Description and Business Overview 7.12.3 Cinfa Dimenhydrinate Sales, Revenue and Gross Margin (2017-2022) 7.12.4 Cinfa Products Offered 7.12.5 Cinfa Recent Development 7.13 Neuraxpharm Arzneimittel 7.13.1 Neuraxpharm Arzneimittel Corporation Information 7.13.2 Neuraxpharm Arzneimittel Description and Business Overview 7.13.3 Neuraxpharm Arzneimittel Dimenhydrinate Sales, Revenue and Gross Margin (2017-2022) 7.13.4 Neuraxpharm Arzneimittel Products Offered 7.13.5 Neuraxpharm Arzneimittel Recent Development 7.14 Gedeon Richter 7.14.1 Gedeon Richter Corporation Information 7.14.2 Gedeon Richter Description and Business Overview 7.14.3 Gedeon Richter Dimenhydrinate Sales, Revenue and Gross Margin (2017-2022) 7.14.4 Gedeon Richter Products Offered 7.14.5 Gedeon Richter Recent Development 7.15 Medrock Biotech 7.15.1 Medrock Biotech Corporation Information 7.15.2 Medrock Biotech Description and Business Overview 7.15.3 Medrock Biotech Dimenhydrinate Sales, Revenue and Gross Margin (2017-2022) 7.15.4 Medrock Biotech Products Offered 7.15.5 Medrock Biotech Recent Development 7.16 Strides Pharma 7.16.1 Strides Pharma Corporation Information 7.16.2 Strides Pharma Description and Business Overview 7.16.3 Strides Pharma Dimenhydrinate Sales, Revenue and Gross Margin (2017-2022) 7.16.4 Strides Pharma Products Offered 7.16.5 Strides Pharma Recent Development 7.17 Fresenius 7.17.1 Fresenius Corporation Information 7.17.2 Fresenius Description and Business Overview 7.17.3 Fresenius Dimenhydrinate Sales, Revenue and Gross Margin (2017-2022) 7.17.4 Fresenius Products Offered 7.17.5 Fresenius Recent Development 7.18 Novartis 7.18.1 Novartis Corporation Information 7.18.2 Novartis Description and Business Overview 7.18.3 Novartis Dimenhydrinate Sales, Revenue and Gross Margin (2017-2022) 7.18.4 Novartis Products Offered 7.18.5 Novartis Recent Development 7.19 Johnson and Johnson 7.19.1 Johnson and Johnson Corporation Information 7.19.2 Johnson and Johnson Description and Business Overview 7.19.3 Johnson and Johnson Dimenhydrinate Sales, Revenue and Gross Margin (2017-2022) 7.19.4 Johnson and Johnson Products Offered 7.19.5 Johnson and Johnson Recent Development 7.20 Yoshindo 7.20.1 Yoshindo Corporation Information 7.20.2 Yoshindo Description and Business Overview 7.20.3 Yoshindo Dimenhydrinate Sales, Revenue and Gross Margin (2017-2022) 7.20.4 Yoshindo Products Offered 7.20.5 Yoshindo Recent Development 7.21 IFET 7.21.1 IFET Corporation Information 7.21.2 IFET Description and Business Overview 7.21.3 IFET Dimenhydrinate Sales, Revenue and Gross Margin (2017-2022) 7.21.4 IFET Products Offered 7.21.5 IFET Recent Development 7.22 Bayer 7.22.1 Bayer Corporation Information 7.22.2 Bayer Description and Business Overview 7.22.3 Bayer Dimenhydrinate Sales, Revenue and Gross Margin (2017-2022) 7.22.4 Bayer Products Offered 7.22.5 Bayer Recent Development 7.23 Nidda Healthcare 7.23.1 Nidda Healthcare Corporation Information 7.23.2 Nidda Healthcare Description and Business Overview 7.23.3 Nidda Healthcare Dimenhydrinate Sales, Revenue and Gross Margin (2017-2022) 7.23.4 Nidda Healthcare Products Offered 7.23.5 Nidda Healthcare Recent Development 7.24 Medifarma 7.24.1 Medifarma Corporation Information 7.24.2 Medifarma Description and Business Overview 7.24.3 Medifarma Dimenhydrinate Sales, Revenue and Gross Margin (2017-2022) 7.24.4 Medifarma Products Offered 7.24.5 Medifarma Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 Dimenhydrinate Industry Chain Analysis 8.2 Dimenhydrinate Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 Dimenhydrinate Distributors 8.3 Dimenhydrinate Production Mode & Process 8.4 Dimenhydrinate Sales and Marketing 8.4.1 Dimenhydrinate Sales Channels 8.4.2 Dimenhydrinate Distributors 8.5 Dimenhydrinate Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer

List of Tables Table 1. Dimenhydrinate CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Dimenhydrinate Market Trends Table 3. Dimenhydrinate Market Drivers Table 4. Dimenhydrinate Market Challenges Table 5. Dimenhydrinate Market Restraints Table 6. Global Dimenhydrinate Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Dimenhydrinate Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Dimenhydrinate Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Dimenhydrinate Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Dimenhydrinate Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Dimenhydrinate Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Dimenhydrinate Revenue Share by Manufacturer, 2017-2022 Table 13. Global Dimenhydrinate Sales by Manufacturer, (K Units), 2017-2022 Table 14. Global Dimenhydrinate Sales Share by Manufacturer, 2017-2022 Table 15. Global Dimenhydrinate Price by Manufacturer (2017-2022) & (US$/Unit) Table 16. Global Dimenhydrinate Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Dimenhydrinate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dimenhydrinate as of 2021) Table 18. Top Players of Dimenhydrinate in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Dimenhydrinate Product Type Table 20. Date of International Manufacturers Enter into Dimenhydrinate Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Dimenhydrinate Players in United States Market, Ranking by Revenue (2021) Table 23. United States Dimenhydrinate Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Dimenhydrinate Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Dimenhydrinate Sales by Players, (K Units), 2020, 2021 & 2022 Table 26. United States Dimenhydrinate Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Dimenhydrinate Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Dimenhydrinate Sales in Volume by Region (2017-2022) & (K Units) Table 29. Global Dimenhydrinate Sales in Volume Forecast by Region (2023-2028) & (K Units) Table 30. Global Dimenhydrinate Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Dimenhydrinate Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Dimenhydrinate Sales in Volume by Country (2017-2028) & (K Units) Table 33. North America Dimenhydrinate Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Dimenhydrinate Sales in Volume by Region (2017-2028) & (K Units) Table 35. Asia Pacific Dimenhydrinate Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Dimenhydrinate Sales in Volume by Country (2017-2028) & (K Units) Table 37. Europe Dimenhydrinate Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Dimenhydrinate Sales in Volume by Country (2017-2028) & (K Units) Table 39. Latin Americaa Dimenhydrinate Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Dimenhydrinate Sales in Volume by Country (2017-2028) & (K Units) Table 41. Middle East and Africa Dimenhydrinate Sales in Value by Country (2017-2028) & (US$ Million) Table 42. Bristol-Myers Squibb Corporation Information Table 43. Bristol-Myers Squibb Description and Business Overview Table 44. Bristol-Myers Squibb Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 45. Bristol-Myers Squibb Dimenhydrinate Product Table 46. Bristol-Myers Squibb Recent Development Table 47. Baxter Healthcare Corporation Information Table 48. Baxter Healthcare Description and Business Overview Table 49. Baxter Healthcare Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 50. Baxter Healthcare Product Table 51. Baxter Healthcare Recent Development Table 52. Watson Laboratories Corporation Information Table 53. Watson Laboratories Description and Business Overview Table 54. Watson Laboratories Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 55. Watson Laboratories Product Table 56. Watson Laboratories Recent Development Table 57. Pfizer Corporation Information Table 58. Pfizer Description and Business Overview Table 59. Pfizer Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 60. Pfizer Product Table 61. Pfizer Recent Development Table 62. Nexgen Pharma Corporation Information Table 63. Nexgen Pharma Description and Business Overview Table 64. Nexgen Pharma Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 65. Nexgen Pharma Product Table 66. Nexgen Pharma Recent Development Table 67. Goodwill Pharma Corporation Information Table 68. Goodwill Pharma Description and Business Overview Table 69. Goodwill Pharma Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 70. Goodwill Pharma Product Table 71. Goodwill Pharma Recent Development Table 72. Hennig Arzneimittel Corporation Information Table 73. Hennig Arzneimittel Description and Business Overview Table 74. Hennig Arzneimittel Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 75. Hennig Arzneimittel Product Table 76. Hennig Arzneimittel Recent Development Table 77. Zambon Corporation Information Table 78. Zambon Description and Business Overview Table 79. Zambon Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 80. Zambon Product Table 81. Zambon Recent Development Table 82. Apotex Corporation Information Table 83. Apotex Description and Business Overview Table 84. Apotex Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 85. Apotex Product Table 86. Apotex Recent Development Table 87. Teva Corporation Information Table 88. Teva Description and Business Overview Table 89. Teva Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 90. Teva Product Table 91. Teva Recent Development Table 92. Mylan Corporation Information Table 93. Mylan Description and Business Overview Table 94. Mylan Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 95. Mylan Product Table 96. Mylan Recent Development Table 97. Cinfa Corporation Information Table 98. Cinfa Description and Business Overview Table 99. Cinfa Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 100. Cinfa Product Table 101. Cinfa Recent Development Table 102. Neuraxpharm Arzneimittel Corporation Information Table 103. Neuraxpharm Arzneimittel Description and Business Overview Table 104. Neuraxpharm Arzneimittel Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 105. Neuraxpharm Arzneimittel Product Table 106. Neuraxpharm Arzneimittel Recent Development Table 107. Gedeon Richter Corporation Information Table 108. Gedeon Richter Description and Business Overview Table 109. Gedeon Richter Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 110. Gedeon Richter Product Table 111. Gedeon Richter Recent Development Table 112. Medrock Biotech Corporation Information Table 113. Medrock Biotech Description and Business Overview Table 114. Medrock Biotech Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 115. Medrock Biotech Product Table 116. Medrock Biotech Recent Development Table 117. Strides Pharma Corporation Information Table 118. Strides Pharma Description and Business Overview Table 119. Strides Pharma Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 120. Strides Pharma Product Table 121. Strides Pharma Recent Development Table 122. Fresenius Corporation Information Table 123. Fresenius Description and Business Overview Table 124. Fresenius Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 125. Fresenius Product Table 126. Fresenius Recent Development Table 127. Novartis Corporation Information Table 128. Novartis Description and Business Overview Table 129. Novartis Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 130. Novartis Product Table 131. Novartis Recent Development Table 132. Johnson and Johnson Corporation Information Table 133. Johnson and Johnson Description and Business Overview Table 134. Johnson and Johnson Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 135. Johnson and Johnson Product Table 136. Johnson and Johnson Recent Development Table 137. Yoshindo Corporation Information Table 138. Yoshindo Description and Business Overview Table 139. Yoshindo Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 140. Yoshindo Product Table 141. Yoshindo Recent Development Table 142. IFET Corporation Information Table 143. IFET Description and Business Overview Table 144. IFET Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 145. IFET Product Table 146. IFET Recent Development Table 147. Bayer Corporation Information Table 148. Bayer Description and Business Overview Table 149. Bayer Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 150. Bayer Product Table 151. Bayer Recent Development Table 152. Nidda Healthcare Corporation Information Table 153. Nidda Healthcare Description and Business Overview Table 154. Nidda Healthcare Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 155. Nidda Healthcare Product Table 156. Nidda Healthcare Recent Development Table 157. Medifarma Corporation Information Table 158. Medifarma Description and Business Overview Table 159. Medifarma Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 160. Medifarma Product Table 161. Medifarma Recent Development Table 162. Key Raw Materials Lists Table 163. Raw Materials Key Suppliers Lists Table 164. Dimenhydrinate Customers List Table 165. Dimenhydrinate Distributors List Table 166. Research Programs/Design for This Report Table 167. Key Data Information from Secondary Sources Table 168. Key Data Information from Primary Sources List of Figures Figure 1. Dimenhydrinate Product Picture Figure 2. Global Dimenhydrinate Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Dimenhydrinate Market Size 2017-2028 (US$ Million) Figure 4. Global Dimenhydrinate Sales 2017-2028 (K Units) Figure 5. United States Dimenhydrinate Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Dimenhydrinate Market Size 2017-2028 (US$ Million) Figure 7. United States Dimenhydrinate Sales 2017-2028 (K Units) Figure 8. United States Dimenhydrinate Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Dimenhydrinate Market Share in Global, in Volume (K Units) 2017-2028 Figure 10. Dimenhydrinate Report Years Considered Figure 11. Product Picture of Oral Figure 12. Product Picture of Injection Figure 13. Global Dimenhydrinate Market Share by Type in 2022 & 2028 Figure 14. Global Dimenhydrinate Sales in Value by Type (2017-2028) & (US$ Million) Figure 15. Global Dimenhydrinate Sales Market Share in Value by Type (2017-2028) Figure 16. Global Dimenhydrinate Sales by Type (2017-2028) & (K Units) Figure 17. Global Dimenhydrinate Sales Market Share in Volume by Type (2017-2028) Figure 18. Global Dimenhydrinate Price by Type (2017-2028) & (US$/Unit) Figure 19. United States Dimenhydrinate Market Share by Type in 2022 & 2028 Figure 20. United States Dimenhydrinate Sales in Value by Type (2017-2028) & (US$ Million) Figure 21. United States Dimenhydrinate Sales Market Share in Value by Type (2017-2028) Figure 22. United States Dimenhydrinate Sales by Type (2017-2028) & (K Units) Figure 23. United States Dimenhydrinate Sales Market Share in Volume by Type (2017-2028) Figure 24. United States Dimenhydrinate Price by Type (2017-2028) & (US$/Unit) Figure 25. Product Picture of Hospital Figure 26. Product Picture of Drug Store Figure 27. Product Picture of On-line Figure 28. Global Dimenhydrinate Market Share by Application in 2022 & 2028 Figure 29. Global Dimenhydrinate Sales in Value by Application (2017-2028) & (US$ Million) Figure 30. Global Dimenhydrinate Sales Market Share in Value by Application (2017-2028) Figure 31. Global Dimenhydrinate Sales by Application (2017-2028) & (K Units) Figure 32. Global Dimenhydrinate Sales Market Share in Volume by Application (2017-2028) Figure 33. Global Dimenhydrinate Price by Application (2017-2028) & (US$/Unit) Figure 34. United States Dimenhydrinate Market Share by Application in 2022 & 2028 Figure 35. United States Dimenhydrinate Sales in Value by Application (2017-2028) & (US$ Million) Figure 36. United States Dimenhydrinate Sales Market Share in Value by Application (2017-2028) Figure 37. United States Dimenhydrinate Sales by Application (2017-2028) & (K Units) Figure 38. United States Dimenhydrinate Sales Market Share in Volume by Application (2017-2028) Figure 39. United States Dimenhydrinate Price by Application (2017-2028) & (US$/Unit) Figure 40. North America Dimenhydrinate Sales in Volume Growth Rate 2017-2028 (K Units) Figure 41. North America Dimenhydrinate Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 42. United States Dimenhydrinate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 43. Canada Dimenhydrinate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 44. Europe Dimenhydrinate Sales in Volume Growth Rate 2017-2028 (K Units) Figure 45. Europe Dimenhydrinate Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 46. Germany Dimenhydrinate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 47. France Dimenhydrinate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 48. U.K. Dimenhydrinate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. Italy Dimenhydrinate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 50. Russia Dimenhydrinate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 51. Asia-Pacific Dimenhydrinate Sales in Volume Growth Rate 2017-2028 (K Units) Figure 52. Asia-Pacific Dimenhydrinate Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 53. China Dimenhydrinate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 54. Japan Dimenhydrinate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 55. South Korea Dimenhydrinate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. India Dimenhydrinate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 57. Australia Dimenhydrinate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. China Taiwan Dimenhydrinate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. Indonesia Dimenhydrinate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. Thailand Dimenhydrinate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Malaysia Dimenhydrinate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Latin America Dimenhydrinate Sales in Volume Growth Rate 2017-2028 (K Units) Figure 63. Latin America Dimenhydrinate Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 64. Mexico Dimenhydrinate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 65. Brazil Dimenhydrinate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 66. Argentina Dimenhydrinate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 67. Middle East & Africa Dimenhydrinate Sales in Volume Growth Rate 2017-2028 (K Units) Figure 68. Middle East & Africa Dimenhydrinate Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 69. Turkey Dimenhydrinate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 70. Saudi Arabia Dimenhydrinate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 71. UAE Dimenhydrinate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 72. Dimenhydrinate Value Chain Figure 73. Dimenhydrinate Production Process Figure 74. Channels of Distribution Figure 75. Distributors Profiles Figure 76. Bottom-up and Top-down Approaches for This Report Figure 77. Data Triangulation Figure 78. Key Executives Interviewed

Bristol-Myers Squibb Baxter Healthcare Watson Laboratories Pfizer Nexgen Pharma Goodwill Pharma Hennig Arzneimittel Zambon Apotex Teva Mylan Cinfa Neuraxpharm Arzneimittel Gedeon Richter Medrock Biotech Strides Pharma Fresenius Novartis Johnson and Johnson Yoshindo IFET Bayer Nidda Healthcare Medifarma